Advertisement
Screener

PAVmed Inc. (PAVM) Cash and Cash Equivalents, Period Increase (Decrease)

1.8 / 5 stars · 20/56 Roast Me

PAVmed Inc. Cash and Cash Equivalents, Period Increase (Decrease)

PAVmed Inc. (PAVM) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$4.03 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-15

  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$4.03M, a 292.38% decline year-over-year.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$1.02M.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$1.90M, a 162.59% decline year-over-year.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $7.51M.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $6.69M, a 604.39% increase from fiscal 2017.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $949.34K.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$181.59K.
  • PAVmed Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$71.81K.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2019-03-31-$4.03M
10-Q · filed 2019-05-15
-$5.05M
derived: sum of 2 quarters · filed 2019-05-15
-$6.95M
derived: sum of 3 quarters · filed 2019-05-15
$559.75K
derived: sum of 4 quarters · filed 2019-05-15
2018-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$2.92M
derived: sum of 2 quarters · filed 2019-04-01
$4.59M
derived: sum of 3 quarters · filed 2019-04-01
$6.69M
10-K · filed 2019-04-01
2018-09-30-$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$5.61M
derived: sum of 2 quarters · filed 2018-11-14
$7.71M
10-Q · filed 2018-11-14
$6.13M
derived: sum of 4 quarters · filed 2019-05-15
2018-06-30$7.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$9.60M
10-Q · filed 2018-08-13
$8.03M
derived: sum of 3 quarters · filed 2019-05-15
$11.06M
derived: sum of 4 quarters · filed 2019-05-15
2018-03-31$2.10M
10-Q · filed 2019-05-15
$519.24K
derived: sum of 2 quarters · filed 2019-05-15
$3.55M
derived: sum of 3 quarters · filed 2019-05-15
$2.73M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31-$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$1.45M
derived: sum of 2 quarters · filed 2019-04-01
$629.37K
derived: sum of 3 quarters · filed 2019-04-01
$949.34K
10-K · filed 2019-04-01
2017-09-30$3.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$2.21M
derived: sum of 2 quarters · filed 2018-11-14
$2.53M
10-Q · filed 2018-11-14
$1.32M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$823.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
-$503.63K
10-Q · filed 2018-08-13
-$1.71M
derived: sum of 3 quarters · filed 2018-08-13
-$2.94M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31$319.98K
10-Q · filed 2018-05-21
-$882.99K
derived: sum of 2 quarters · filed 2018-05-21
-$2.12M
derived: sum of 3 quarters · filed 2018-05-21
$669.60K
derived: sum of 4 quarters · filed 2018-05-21
2016-12-31-$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$2.44M
derived: sum of 2 quarters · filed 2018-03-14
$349.63K
derived: sum of 3 quarters · filed 2018-03-14
-$181.59K
10-K · filed 2018-03-14
2016-09-30-$1.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$1.55M
derived: sum of 2 quarters · filed 2017-11-14
$1.02M
10-Q · filed 2017-11-14
$373.36K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$2.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11
$2.26M
10-Q · filed 2017-08-11
$1.61M
derived: sum of 3 quarters · filed 2017-08-11
$2.50M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31-$531.22K
10-Q · filed 2017-05-22
-$1.18M
derived: sum of 2 quarters · filed 2017-05-22
-$285.52K
derived: sum of 3 quarters · filed 2017-05-22
-$493.15K
derived: sum of 4 quarters · filed 2017-05-22
2015-12-31-$648.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$245.70K
derived: sum of 2 quarters · filed 2017-02-16
$38.06K
derived: sum of 3 quarters · filed 2017-02-16
-$71.81K
10-K · filed 2017-02-16
2015-09-30$893.72K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$686.09K
derived: sum of 2 quarters · filed 2016-11-10
$576.22K
10-Q · filed 2016-11-10
2015-06-30-$207.63K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-12
-$317.50K
10-Q · filed 2016-08-12
2015-03-31-$109.87K
10-Q/A · filed 2016-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14